A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
Cancer Medicine · 2023
DOI: 10.1002/cam4.6551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Qiao He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliate…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Medical Association, Sichuan Provincial Cadre Health Research Project, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Background
Mean platelet volume (MPV), as a marker of platelet activity, has been shown to be an efficient prognostic biomarker in several types of cancer. Using MPV, this study aimed to create and validate a prognostic nomogram to the overall survival in esophageal squamous cell carcinoma (ESCC) patients.
Methods
The nomogram was constructed and tested using data from a retrospective study of 1893 patients who were randomly assigned to the training and testing cohorts with a 7:3 randomization. In order to screen out the optimal predictors for overall survival (OS), we conducted the LASSO‐cox regression, univariate, and multivariate cox regression analyses. Subsequently, the predictive accuracy of the nomogram was validated in both the training and the testing cohorts. Finally, decision curve analysis (DCA) was used to confirm clinical validity.
Results
Age, MPV, nerve invasion, T stage, and N stage were found as independent prognostic variables for OS and were further developed into a nomogram. The nomogram's prediction accuracy for 1‐, 3‐, and 5‐year OS was 0.736, 0.749, 0.774, and 0.724, 0.719, 0.704 in the training and testing cohorts, respectively. Furthermore, DCA results indicated that nomograms outperformed the AJCC 8th and conventional T, N staging systems in both the training and testing cohorts.
Conclusions
The nomogram, in conjunction with MPV and standard clinicopathological markers, could improve the accuracy of prediction of OS in ESCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology o…
- Department of Transfusion Medicine, West China Hospital, Sichuan University, Chengdu, China.
- Centre for Translational Research in Cancer, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Te…
- Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of…
ORCID-Profile: Qiao He
Förderung
- Sichuan Medical Association
- Sichuan Provincial Cadre Health Research Project
- Sichuan Science and Technology Program
Zitieren
APA
He, Q., Luo, Z., Zou, H., Ye, B., Wu, L., Deng, Y., Yang, M., Wang, D., Wang, Q., & Zhang, K. (2023). A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6551
Vancouver
He Q, Luo Z, Zou H, Ye B, Wu L, Deng Y, et al. A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.6551
BibTeX
@article{He2023,
author = {He, Qiao and Luo, Zhenglian and Zou, Haiming and Ye, Bo and Wu, Lichun and Deng, Yao and Yang, Mu and Wang, Dongsheng and Wang, Qifeng and Zhang, Kaijiong},
title = {A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6551}
}
EUVIMED